Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 15, 2026

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
15:55

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

Ligand-Mediated Reprogramming Redirects Liver-Tropic Ionizable Lipid Nanoparticles for Lung-Selective mRNA Delivery.

Zhuxiao Gu1,2, Xinhong Xiong3, Xiang Chen1

  • 1Department of Cardiology, Cardiovascular Disease Center, Institute of Clinical Medicine, Jiangsu Key Laboratory For Cardiovascular Information and Health Engineering Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.

Angewandte Chemie (International Ed. in English)
|July 13, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Digital heart initiative: an ecosystem for digital discovery and precision medicine in cardiology.

National science review·2026
Same author

Field‑Programmable Biofunctional Films: From Assisted Fabrication to Integrated Diagnostic-Therapeutic Devices.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Gene regulatory networks orchestrating oocyte fate bifurcation in primordial follicles revealed by single-cell transcriptomics.

Communications biology·2026
Same author

Using Well-Defined DNA Nanostructures To Study the Influence of DNA Clustering and Presentation on SNA Cellular Uptake.

Nano letters·2026
Same author

Iron-Photocatalyzed C(sp<sup>3</sup>)-H Phosphonylation of Alkanes.

Angewandte Chemie (International ed. in English)·2026

Researchers repurposed liver-targeting lipid nanoparticles (LNPs) for lung-specific messenger RNA (mRNA) delivery. This novel ligand-mediated reprogramming enhances mRNA translation in the lungs, advancing gene therapy applications.

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Nanomedicine

Background:

  • Lipid nanoparticles (LNPs) are crucial for systemic messenger RNA (mRNA) delivery, but often show liver tropism.
  • Modifying LNP organ specificity without new chemistry is a significant challenge in gene therapy development.

Purpose of the Study:

  • To develop a method for reprogramming existing liver-tropic LNPs for targeted mRNA delivery to other organs, specifically the lungs.
  • To engineer novel lipidoid formulations for enhanced tissue-specific mRNA delivery and therapeutic applications.

Main Methods:

  • Screened a library of 90 degradable lipidoids to identify a liver-targeting platform (2-t6b).
  • Engineered reconfigured lipidoids by attaching small molecule ligands to the 2-t6b headgroup for lung targeting.
Keywords:
extrahepatic targetingionizable lipidlipid nanoparticlemRNA delivery

More Related Videos

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Related Experiment Videos

Last Updated: Jul 15, 2026

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
15:55

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

  • Utilized proteomics and molecular docking to elucidate the mechanism of enhanced cellular uptake and translation.
  • Main Results:

    • Engineered LNPs achieved over 200-fold higher mRNA translation in the lungs compared to parent liver-tropic LNPs.
    • Identified enhanced binding to vitronectin as a key factor in improved cellular uptake and translation efficiency.
    • Demonstrated superior efficacy in lung-specific genome editing using ligand-mediated reprogrammed LNPs.

    Conclusions:

    • A modular, ligand-mediated lipid reprogramming strategy can repurpose liver-biased LNPs for lung-selective mRNA delivery.
    • This approach offers a generalizable framework for developing next-generation tissue-specific mRNA therapies.
    • Advances in gene editing, protein replacement, and regenerative medicine are facilitated by this targeted delivery system.